Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc.AMRX · Entity 820 | Director | May 06, 2026 | May 08, 2026 |
| Aptiv PLCAPTV · Entity 3559 | Director | August 05, 2026 | August 06, 2026 |
| Hims & Hers Health, Inc.OAC · Entity 1878 | Director | July 17, 2019 | July 18, 2019 |
| LKQ CORPLKQ · Entity 1128 | Director | May 08, 2017 | May 10, 2017 |
| Light & Wonder, Inc.SGMS · Entity 9758 | Director | June 10, 2020 | June 12, 2020 |
| Oaktree Acquisition Corp. IIOACB · Entity 142657 | Director | September 16, 2020 | September 16, 2020 |
| Oaktree Acquisition Corp. III Life SciencesOACC · Entity 6078 | Director | October 23, 2024 | October 24, 2024 |
| Quanterix CorpQTRX · Entity 6649 | Director | January 02, 2026 | January 15, 2026 |
| THERMO FISHER SCIENTIFIC INC.TMO · Entity 2836 | Director | January 05, 2007 | January 09, 2007 |
| Telesis Bio Inc.TBIO · Entity 15606 | Director · 10% owner | June 06, 2023 | June 08, 2023 |
| Versigent PLCVGNT · Entity 4179 | Director | September 18, 2026 | September 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Amneal Pharmaceuticals, Inc.
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 832,800 |
Reported balance
After 2026-05-07 transaction · row 1
1 source rowRow 1 · 2026-05-07 · Exercise / conversion · Acquired 48,747 · Balance 832,800 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-07 · Exercise / conversion · Disposed 48,747 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2: On May 6, 2025, the reporting person was granted 48,747 restricted stock units vesting on May 7, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 30,837 |
Reported balance
After 2026-05-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-06 · Grant · Acquired 30,837 · Balance 30,837 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2: On May 6, 2025, the reporting person was granted 48,747 restricted stock units vesting on May 7, 2026.
F3: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.
Aptiv PLC
Report date August 05, 2026 · Filed August 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | IndirectWoburn Abbey March 2021 Trust GST Exempt Share | 105,631 |
Reported balance
After 2026-08-05 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-08-05 · Purchase · Acquired 105,631 · Balance 105,631 |
| Ordinary SharesSEC Table I · non-derivative | Direct | 13,612 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 13,612 |
| Ordinary SharesSEC Table I · non-derivative | IndirectPaul M. Meister 2005 Revocable Trust | 19,181 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 19,181 |
Hims & Hers Health, Inc.
Report date July 17, 2019 · Filed July 18, 2019
This filing explicitly reported no securities owned.
LKQ CORP
Report date May 08, 2017 · Filed May 10, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 272,067 |
Reported balance
After 2017-05-08 transaction · row 1
1 source rowRow 1 · 2017-05-08 · Grant · Acquired 3,662 · Balance 272,067 F1: The transaction represents an award of restricted stock units that vest with respect to 100% of the number of shares subject to the award on the earlier of (a) the one-year anniversary of the grant date, and (b) the date of the 2018 Annual Meeting of Stockholders of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction represents an award of restricted stock units that vest with respect to 100% of the number of shares subject to the award on the earlier of (a) the one-year anniversary of the grant date, and (b) the date of the 2018 Annual Meeting of Stockholders of the Issuer.
Light & Wonder, Inc.
Report date June 10, 2020 · Filed June 12, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 82,740 |
Reported balance
After 2020-06-10 transaction · row 1
1 source rowRow 1 · 2020-06-10 · Exercise / conversion · Acquired 25,622 · Balance 82,740 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-06-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-06-10 · Exercise / conversion · Disposed 7,710 · Balance 0 F1: Represents vesting of restricted stock units granted on June 12, 2019 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-06-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-06-10 · Exercise / conversion · Disposed 2,091 · Balance 0 F2: Represents vesting of the remaining restricted stock units granted on June 13, 2018 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-06-10 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-06-10 · Exercise / conversion · Disposed 4,339 · Balance 0 F3: Represents vesting of the remaining restricted stock units granted on June 15, 2016 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-06-10 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-06-10 · Exercise / conversion · Disposed 3,110 · Balance 0 F4: Represents vesting of the remaining restricted stock units granted on June 19, 2017 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 8,372 |
Reported balance
After 2020-06-10 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-06-10 · Grant · Acquired 8,372 · Balance 8,372 F5: The restricted stock units will vest immediately in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. Each unit converts into a share of common stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-06-10 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-06-10 · Exercise / conversion · Disposed 8,372 · Balance 0 F6: Represents vesting of restricted stock units granted on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents vesting of restricted stock units granted on June 12, 2019 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis.
F2: Represents vesting of the remaining restricted stock units granted on June 13, 2018 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis.
F3: Represents vesting of the remaining restricted stock units granted on June 15, 2016 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis.
F4: Represents vesting of the remaining restricted stock units granted on June 19, 2017 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis.
F5: The restricted stock units will vest immediately in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. Each unit converts into a share of common stock on a one-for-one basis.
F6: Represents vesting of restricted stock units granted on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis.
Oaktree Acquisition Corp. II
Report date September 16, 2020 · Filed September 16, 2020
This filing explicitly reported no securities owned.
Oaktree Acquisition Corp. III Life Sciences
Report date October 23, 2024 · Filed October 24, 2024
This filing explicitly reported no securities owned.
Quanterix Corp
Report date January 02, 2026 · Filed January 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 313,253 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Grant · Acquired 3,974 · Balance 313,253 F1: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the third and fourth quarter of 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the third and fourth quarter of 2025.
THERMO FISHER SCIENTIFIC INC.
Report date January 05, 2007 · Filed January 09, 2007
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 350,000 |
Ending reported balance
After 2007-01-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2007-01-05 · Sale · Disposed 175,000 · Balance 450,000 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2006. F2: The sales price shown is the average sales price for all shares sold on January 5, 2007, actual denominations are as follows: 900 shares at $44.95; 800 shares at $44.96; 600 shares at $44.97; 21,300 shares at $45.00; 6,100 shares at $45.01; 1,800 shares at $45.02; 15,300 shares at $45.05; 400 shares at $45.06; 2,400 shares at $45.07; 6,600 shares at $45.08; 300 shares at $45.09; 77,300 shares at $45.50; 200 shares at $45.52; 200 shares at $45.53; 36,300 shares at $45.55; 3,500 shares at $45.56; 600 shares at $45.58; and 400 shares at $45.59. Row 2 · 2007-01-08 · Sale · Disposed 100,000 · Balance 350,000 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2006. F3: The sales price shown is the average sales price for all shares sold on January 8, 2007, actual denominations are as follows: 12,400 shares at $44.90; 1,400 shares at $44.91; 2,800 shares at $44.92; 15,500 shares at $44.93; 500 shares at $44.94; 40,800 shares at $44.95; 1,900 shares at $44.97; 4,700 shares at $45.00; and 20,000 shares at $45.10. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2006.
F2: The sales price shown is the average sales price for all shares sold on January 5, 2007, actual denominations are as follows: 900 shares at $44.95; 800 shares at $44.96; 600 shares at $44.97; 21,300 shares at $45.00; 6,100 shares at $45.01; 1,800 shares at $45.02; 15,300 shares at $45.05; 400 shares at $45.06; 2,400 shares at $45.07; 6,600 shares at $45.08; 300 shares at $45.09; 77,300 shares at $45.50; 200 shares at $45.52; 200 shares at $45.53; 36,300 shares at $45.55; 3,500 shares at $45.56; 600 shares at $45.58; and 400 shares at $45.59.
F3: The sales price shown is the average sales price for all shares sold on January 8, 2007, actual denominations are as follows: 12,400 shares at $44.90; 1,400 shares at $44.91; 2,800 shares at $44.92; 15,500 shares at $44.93; 500 shares at $44.94; 40,800 shares at $44.95; 1,900 shares at $44.97; 4,700 shares at $45.00; and 20,000 shares at $45.10.
Telesis Bio Inc.
Report date June 06, 2023 · Filed June 08, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 108,270 |
Reported balance
After 2023-06-06 transaction · row 1
1 source rowRow 1 · 2023-06-06 · Grant · Acquired 108,270 · Balance 108,270 F1: Represents a grant of restricted stock units. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.33 · Expires 2033-06-06 | Direct | 162,406 |
Reported balance
After 2023-06-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-06-06 · Grant · Acquired 162,406 · Balance 162,406 F2: The options vest in equal monthly installments over a three-year period from the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units.
F2: The options vest in equal monthly installments over a three-year period from the grant date.
Versigent PLC
Report date September 18, 2026 · Filed September 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 14.65 |
Reported balance
After 2026-09-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-18 · Grant · Acquired 14.65 · Balance 14.65 F1: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares. |
Filing footnotes · ownership attribution and instrument terms
F1: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 09, 2022 Filed May 10, 2022 22:46 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | GrantRestricted Stock Units · Derivative | 112,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028158 · doc4.xml · derivative · entry 3 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,179 Underlying: Class A Common Stock · 112,179 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. F3 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Read SEC document |
| May 08, 2022 Filed May 10, 2022 22:46 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionRestricted Stock Units · Derivative | 52,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028158 · doc4.xml · derivative · entry 2 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 52,677 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: On May 5, 2021 the reporting person was granted 52,677 restricted stock units vesting on May 8, 2022. F2 · derivative.expiration_date: On May 5, 2021 the reporting person was granted 52,677 restricted stock units vesting on May 8, 2022. Read SEC document |
| May 08, 2022 Filed May 10, 2022 22:46 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionClass A Common Stock | 52,677 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-028158 · doc4.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 508,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| April 27, 2022 Filed Apr 28, 2022 20:22 UTC | Aptiv PLC APTV · Entity 3559 | GrantOrdinary Shares | 3,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025995 · doc4.xml · nonDerivative · entry 2 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,362 F2 · price: The Reporting Person has received restricted stock units that each represent a right to receive one ordinary share of the Issuer pursuant to the Issuer's Long Term Incentive Plan and will vest in full one day before the Issuer's Annual Meeting of Shareholders in 2023. Read SEC document |
| April 26, 2022 Filed Apr 28, 2022 20:22 UTC | Aptiv PLC APTV · Entity 3559 | Tax withholdingOrdinary Shares | 187 | $102.51 | $19,169.37 |
DisclosureSEC source: 0001209191-22-025995 · doc4.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,794 F1 · price: Shares withheld to pay tax liabilities incident to the vesting of restricted stock units. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:03 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 492 | $30.47 | $14,991.24 |
DisclosureSEC source: 0001562180-22-003221 · primarydocument.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,414 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the first quarter of 2022. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on April 1, 2022. F3 · balance_after: Includes 2,668 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:05 UTC | Quanterix Corp QTRX · Entity 6649 | GrantStock Option (Right to Buy) · Derivative | 4,002 | $0.00 Strike: $42.41 | $0.00 |
DisclosureSEC source: 0001562180-22-000225 · primarydocument.xml · derivative · entry 3 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,002 Underlying: Common Stock · 4,002 shares Expires 2032-01-03 F5 · shares: Represents non-qualified stock option to purchase 4,002 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:05 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 324 | $42.41 | $13,740.84 |
DisclosureSEC source: 0001562180-22-000225 · primarydocument.xml · nonDerivative · entry 2 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,922 F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2021. F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 3, 2022. F2 · balance_after: Includes 2,668 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:05 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 2,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000225 · primarydocument.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,598 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2022 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,668 restricted stock units. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:01 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 269 | $51.18 | $13,767.42 |
DisclosureSEC source: 0001562180-21-006296 · primarydocument.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,930 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the third quarter of 2021. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on October 1, 2021. F3 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:16 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 231 | $59.48 | $13,739.88 |
DisclosureSEC source: 0001562180-21-004770 · primarydocument.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,661 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the second quarter of 2021. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on July 1, 2021. F3 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| May 06, 2021 Filed May 7, 2021 18:07 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionRestricted Stock Units · Derivative | 74,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-030811 · doc4.xml · derivative · entry 3 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 74,230 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: On May 5, 2020 the reporting person was granted 46,218 restricted stock units vesting on May 6, 2021. F3 · derivative.expiration_date: On May 5, 2020 the reporting person was granted 46,218 restricted stock units vesting on May 6, 2021. Read SEC document |
| May 06, 2021 Filed May 7, 2021 18:07 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionClass A Common Stock | 74,230 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-030811 · doc4.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 455,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 05, 2021 Filed May 7, 2021 18:07 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | GrantRestricted Stock Units · Derivative | 52,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-030811 · doc4.xml · derivative · entry 2 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,677 Underlying: Class A Common Stock · 52,677 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. F2 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Read SEC document |
| April 30, 2021 Filed May 3, 2021 18:28 UTC | Aptiv PLC APTV · Entity 3559 | GrantOrdinary Shares | 1,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029437 · doc4.xml · nonDerivative · entry 2 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,981 F2 · price: The Reporting Person has received restricted stock units that each represent a right to receive one ordinary share of the Issuer pursuant to the Issuer's Long Term Incentive Plan and will vest in full one day before the Issuer's Annual Meeting of Shareholders in 2022. Read SEC document |
| April 29, 2021 Filed May 3, 2021 18:28 UTC | Aptiv PLC APTV · Entity 3559 | Tax withholdingOrdinary Shares | 543 | $144.54 | $78,485.22 |
DisclosureSEC source: 0001209191-21-029437 · doc4.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,035 F1 · price: Shares withheld to pay tax liabilities incident to the vesting of restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 3, 2021 01:45 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 223 | $61.45 | $13,703.35 |
DisclosureSEC source: 0001562180-21-002586 · primarydocument.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,430 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the first quarter of 2021. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on April 1, 2021. F3 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:45 UTC | Quanterix Corp QTRX · Entity 6649 | GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $44.10 | $0.00 |
DisclosureSEC source: 0001562180-21-000098 · primarydocument.xml · derivative · entry 3 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2031-01-04 F5 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:45 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 311 | $44.11 | $13,718.21 |
DisclosureSEC source: 0001562180-21-000098 · primarydocument.xml · nonDerivative · entry 2 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,207 F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2020. F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 4, 2021. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:45 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000098 · primarydocument.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,896 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2021 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 21:19 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 396 | $34.70 | $13,741.20 |
DisclosureSEC source: 0001562180-20-006291 · primarydocument.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,626 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the third quarter of 2020, pursuant to an election made in December 2019. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on October 1, 2020. F3 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| August 02, 2020 Filed Aug 4, 2020 12:39 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionRestricted Stock Units · Derivative | 27,923 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-044581 · doc4.xml · derivative · entry 2 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 27,923 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: On August 2, 2019, the reporting person was granted 27,923 restricted stock units vesting on August 2, 2020. F2 · derivative.expiration_date: On August 2, 2019, the reporting person was granted 27,923 restricted stock units vesting on August 2, 2020. Read SEC document |
| August 02, 2020 Filed Aug 4, 2020 12:39 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionClass A Common Stock | 27,923 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-044581 · doc4.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| August 02, 2020 Filed Aug 4, 2020 12:37 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionRestricted Stock Units · Derivative | 27,923 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-044579 · doc4.xml · derivative · entry 2 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 27,923 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: On August 2, 2019, the reporting person was granted 27,923 restricted stock units vesting on August 2, 2020. F2 · derivative.expiration_date: On August 2, 2019, the reporting person was granted 27,923 restricted stock units vesting on August 2, 2020. Read SEC document |
| August 02, 2020 Filed Aug 4, 2020 12:37 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionClass A Common Stock | 27,923 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-044579 · doc4.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| August 02, 2020 Filed Dec 18, 2020 21:13 UTC Amendment | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | Exercise / conversionClass A Common Stock | 27,923 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-064389 · doc4a.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 381,572 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares acquired upon August 2, 2020 vesting of 27,923 restricted stock units, which the reporting person was granted on August 2, 2019. F2 · balance_after: The Amended Form 4 is being filed to reflect the correct amount of securities beneficially owned following the reported transaction. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 20:10 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 494 | $27.80 | $13,733.20 |
DisclosureSEC source: 0001562180-20-004980 · primarydocument.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,230 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the second quarter of 2020, pursuant to an election made in December 2019. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on July 1, 2020. F3 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 20:41 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | Exercise / conversionRestricted Stock Units · Derivative | 8,372 | $0.00 | $0.00 |
DisclosureSEC source: 0000750004-20-000092 · wf-form4_159199445107194.xml · derivative · entry 7 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,372 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Represents vesting of restricted stock units granted on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F6 · derivative.exercise_date: Represents vesting of restricted stock units granted on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F6 · derivative.expiration_date: Represents vesting of restricted stock units granted on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 20:41 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | GrantRestricted Stock Units · Derivative | 8,372 | $0.00 | $0.00 |
DisclosureSEC source: 0000750004-20-000092 · wf-form4_159199445107194.xml · derivative · entry 6 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,372 Underlying: Common Stock · 8,372 shares Expires not disclosed F5 · derivative.exercise_price: The restricted stock units will vest immediately in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. Each unit converts into a share of common stock on a one-for-one basis. F5 · derivative.exercise_date: The restricted stock units will vest immediately in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. Each unit converts into a share of common stock on a one-for-one basis. F5 · derivative.expiration_date: The restricted stock units will vest immediately in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 20:41 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | Exercise / conversionRestricted Stock Units · Derivative | 3,110 | $0.00 | $0.00 |
DisclosureSEC source: 0000750004-20-000092 · wf-form4_159199445107194.xml · derivative · entry 5 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,110 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Represents vesting of the remaining restricted stock units granted on June 19, 2017 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F4 · derivative.exercise_date: Represents vesting of the remaining restricted stock units granted on June 19, 2017 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F4 · derivative.expiration_date: Represents vesting of the remaining restricted stock units granted on June 19, 2017 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 20:41 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | Exercise / conversionRestricted Stock Units · Derivative | 4,339 | $0.00 | $0.00 |
DisclosureSEC source: 0000750004-20-000092 · wf-form4_159199445107194.xml · derivative · entry 4 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Represents vesting of the remaining restricted stock units granted on June 15, 2016 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F3 · derivative.exercise_date: Represents vesting of the remaining restricted stock units granted on June 15, 2016 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F3 · derivative.expiration_date: Represents vesting of the remaining restricted stock units granted on June 15, 2016 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 20:41 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | Exercise / conversionRestricted Stock Units · Derivative | 2,091 | $0.00 | $0.00 |
DisclosureSEC source: 0000750004-20-000092 · wf-form4_159199445107194.xml · derivative · entry 3 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,091 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents vesting of the remaining restricted stock units granted on June 13, 2018 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F2 · derivative.exercise_date: Represents vesting of the remaining restricted stock units granted on June 13, 2018 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F2 · derivative.expiration_date: Represents vesting of the remaining restricted stock units granted on June 13, 2018 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 20:41 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | Exercise / conversionRestricted Stock Units · Derivative | 7,710 | $0.00 | $0.00 |
DisclosureSEC source: 0000750004-20-000092 · wf-form4_159199445107194.xml · derivative · entry 2 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,710 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents vesting of restricted stock units granted on June 12, 2019 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F1 · derivative.exercise_date: Represents vesting of restricted stock units granted on June 12, 2019 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F1 · derivative.expiration_date: Represents vesting of restricted stock units granted on June 12, 2019 in connection with the conclusion of Mr. Meister's service as a director on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 20:41 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | Exercise / conversionCommon Stock | 25,622 | $0.00 | $0.00 |
DisclosureSEC source: 0000750004-20-000092 · wf-form4_159199445107194.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2020 Filed May 6, 2020 23:49 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | GrantRestricted Stock Units · Derivative | 74,230 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-012185 · doc4.xml · derivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,230 Underlying: Class A Common Stock · 74,230 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. F2 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Read SEC document |
| April 23, 2020 Filed Apr 24, 2020 16:59 UTC | Aptiv PLC APTV · Entity 3559 | GrantOrdinary Shares | 4,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025549 · doc4.xml · nonDerivative · entry 3 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,578 F3 · price: The Reporting Person has received restricted stock units that each represent a right to receive one ordinary share of the Issuer pursuant to the Issuer's Long Term Incentive Plan, as amended and restated, and will vest in full one day before the Issuer's Annual Meeting of Shareholders in 2021. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 16:59 UTC | Aptiv PLC APTV · Entity 3559 | OtherDividend Equivalent Right · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025549 · doc4.xml · derivative · entry 4 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 18 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrued when and as dividends were paid on the Issuer's ordinary shares and vest upon the vesting of the restricted stock unit to which they relate. Each dividend equivalent right is the economic equivalent of one ordinary share. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrued when and as dividends were paid on the Issuer's ordinary shares and vest upon the vesting of the restricted stock unit to which they relate. Each dividend equivalent right is the economic equivalent of one ordinary share. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrued when and as dividends were paid on the Issuer's ordinary shares and vest upon the vesting of the restricted stock unit to which they relate. Each dividend equivalent right is the economic equivalent of one ordinary share. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 16:59 UTC | Aptiv PLC APTV · Entity 3559 | Tax withholdingOrdinary Shares | 181 | $60.50 | $10,950.50 |
DisclosureSEC source: 0001209191-20-025549 · doc4.xml · nonDerivative · entry 2 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,214 F2 · price: Shares withheld to pay current tax liabilities incident to the vesting of restricted stock units and settlement of dividend equivalent rights. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 16:59 UTC | Aptiv PLC APTV · Entity 3559 | OtherOrdinary Shares | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025549 · doc4.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,395 F1 · price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrued when and as dividends were paid on the Issuer's ordinary shares and vest upon the vesting of the restricted stock unit to which they relate. Each dividend equivalent right is the economic equivalent of one ordinary share. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:27 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 715 | $19.21 | $13,735.15 |
DisclosureSEC source: 0001562180-20-002881 · primarydocument.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,736 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the first quarter of 2020, pursuant to an election made in December 2019. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on April 1, 2020. F3 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 21:48 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | PurchaseClass A Common Stock | 204,210 | $2.71 | $553,409.10 |
DisclosureSEC source: 0000899243-20-009026 · doc4.xml · nonDerivative · entry 2 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,649 F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.555 to $2.85, inclusive. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 21:48 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | PurchaseClass A Common Stock | 149,439 | $2.79 | $416,934.81 |
DisclosureSEC source: 0000899243-20-009026 · doc4.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,439 F1 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.72 to $2.85, inclusive. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 17:54 UTC | Aptiv PLC APTV · Entity 3559 | GrantDividend Equivalent Right · Derivative | 5.795 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011418 · doc4.xml · derivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17.923 Underlying: Ordinary Shares · 5.795 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued with respect to an outstanding award of restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. F1 · derivative.exercise_date: The dividend equivalent rights accrued with respect to an outstanding award of restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. F1 · derivative.expiration_date: The dividend equivalent rights accrued with respect to an outstanding award of restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:04 UTC | Quanterix Corp QTRX · Entity 6649 | GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $23.12 | $0.00 |
DisclosureSEC source: 0001562180-20-000209 · primarydocument.xml · derivative · entry 3 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2030-01-02 F5 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:04 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 594 | $23.12 | $13,733.28 |
DisclosureSEC source: 0001562180-20-000209 · primarydocument.xml · nonDerivative · entry 2 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,021 F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2019. F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 2, 2020. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:04 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-000209 · primarydocument.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,427 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2020 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 17:24 UTC | Aptiv PLC APTV · Entity 3559 | GrantDividend Equivalent Right · Derivative | 5.859 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-057737 · doc4.xml · derivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12.128 Underlying: Ordinary Shares · 5.859 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued with respect to an outstanding award of restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. F1 · derivative.exercise_date: The dividend equivalent rights accrued with respect to an outstanding award of restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. F1 · derivative.expiration_date: The dividend equivalent rights accrued with respect to an outstanding award of restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:10 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 642 | $21.41 | $13,745.22 |
DisclosureSEC source: 0001562180-19-005099 · primarydocument.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,157 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the third quarter of 2019, pursuant to an election made in December 2018. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on October 1, 2019. F3 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| August 21, 2019 Filed Aug 23, 2019 13:03 UTC | Aptiv PLC APTV · Entity 3559 | GrantDividend Equivalent Right · Derivative | 6.269 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-047216 · doc4.xml · derivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6.269 Underlying: Ordinary Shares · 6.269 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued with respect to an outstanding award of restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. F1 · derivative.exercise_date: The dividend equivalent rights accrued with respect to an outstanding award of restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. F1 · derivative.expiration_date: The dividend equivalent rights accrued with respect to an outstanding award of restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 20:26 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | GrantRestricted Stock Units · Derivative | 27,923 | $0.00 | $0.00 |
DisclosureSEC source: 0001723128-19-000114 · wf-form4_156512314716103.xml · derivative · entry 2 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,923 Underlying: Class A Common Stock · 27,923 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Restricted stock units have no expiration date. F3 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Restricted stock units have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.